The projected savings from Trump's "most-favored nation" pricing policy might be drastically reduced by secretive deals with ...
A late-stage clinical trial found that, when combined with an SMN2-targeting drug, Isembyld caused young patients’ motor ...
Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...
U.S. officials declare an end to record-setting cyclospora outbreak, but its origin is still unknown
The largest cyclospora food poisoning outbreak in U.S. history is over, U.S. health officials said, but questions remain over ...
The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines. They could also have a ...
A newly approved AI tool can scan EKGs for severe heart attacks and, the company says, for rarer patterns indicating blocked ...
A pill from AstraZeneca failed to improve outcomes in closely watched breast cancer study, a result that could limit the use ...
New Medicaid rules use allow use of tiers to determine work exemptions. Advocates fear complex guidelines could cause ...
For thousands of families, the Sept. 11 attack did not end when the fires were extinguished. It simply changed form,” writes ...
When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for ...
About four dozen children who attended a community party in August 2025 later developed skin and soft tissue lesions and ...
The Trump administration is promising to send $500 refund checks to nearly 1 million people with Affordable Care Act health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results